Company page

Apimeds Pharmaceuticals Us, Inc.

Apimeds Pharmaceuticals Us, Inc. (ticker: APUS) is a public company based in America, with a market capitalization of approximately $16.4 million. The company focuses on developing innovative pharmaceutical solutions. Investors can find detailed information about its operations and performance on its public company page.